TABLE OF CONTENTS
1 INTRODUCTION 40
1.1 OBJECTIVES OF THE STUDY 40
1.2 MARKET DEFINITION 40
1.3 OVERVIEW OF THE MIDDLE EAST & AFRICA N95 MASK MARKET 40
1.4 LIMITATION 42
1.5 MARKETS COVERED 42
2 MARKET SEGMENTATION 46
2.1 MARKETS COVERED 46
2.2 GEOGRAPHICAL SCOPE 47
2.3 YEARS CONSIDERED FOR THE STUDY 48
2.4 CURRENCY AND PRICING 48
2.5 DBMR TRIPOD DATA VALIDATION MODEL 49
2.6 MULTIVARIATE MODELLING 52
2.7 PRODUCT SEGMENT LIFELINE CURVE 52
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 53
2.9 DBMR MARKET POSITION GRID 54
2.10 MARKET APPLICATION COVERAGE GRID 55
2.11 VENDOR SHARE ANALYSIS 56
2.12 SECONDARY SOURCES 57
2.13 ASSUMPTIONS 57
3 EXECUTIVE SUMMARY 58
3.1 PESTEL ANALYSIS 62
3.2 PORTER'S FIVE FORCES MODEL 63
4 INDUSTRY INSIGHTS 64
5 MIDDLE EAST & AFRICA N95 MASK MARKET: REGULATORY FRAMEWORK 66
6 MARKET OVERVIEW 69
6.1 DRIVERS 71
6.1.1 INCREASE IN AIR POLLUTION LEVELS 71
6.1.2 RISING PREVALENCE OF RESPIRATORY DISEASES 72
6.1.3 MANDATORY OCCUPATIONAL SAFETY REGULATIONS FOR WORKERS IN VARIOUS INDUSTRY 72
6.1.4 INCREASED AWARENESS ABOUT THE SIGNIFICANT BENEFITS OF THE N95 MASK 74
6.2 RESTRAINTS 75
6.2.1 ENVIRONMENTAL CONCERNS ASSOCIATED WITH THE DISPOSAL OF N95 MASKS 75
6.2.2 INCREASED USE OF HOMEMADE MASK 76
6.3 OPPORTUNITIES 76
6.3.1 TECHNOLOGICAL ADVANCEMENT PROMOTING THE MANUFACTURING OF ECO-FRIENDLY N95 MASKS 76
6.3.2 RISING HEALTH AND SAFETY CONCERNS AGAINST INFECTIOUS DISEASES AMONG THE CONSUMERS 77
6.3.3 SIGNIFICANT RISE IN THE USE OF N95 MASKS IN THE HEALTHCARE INDUSTRY 78
6.4 CHALLENGES 79
6.4.1 LIMITED PRODUCTION CAPACITY AND MACHINERY FOR MEETING THE DESIRED QUALITY OF N95 MASKS 79
6.4.2 PHYSIOLOGICAL EFFECTS ASSOCIATED WITH THE PROLONGED USE OF N95 MASKS 80
7 MIDDLE EAST & AFRICA N95 MASK MARKET, BY PRODUCT 81
7.1 OVERVIEW 82
7.2 STANDARD N95 MASKS 85
7.2.1 BY VALVES 86
7.2.1.1 WITHOUT VALVE 86
7.2.1.2 WITH VALVE 86
7.2.2 BY STYLE 86
7.2.2.1 MOLDED CUP 86
7.2.2.2 FLAT FOLD 86
7.3 SURGICAL N95 MASKS 87
7.3.1 BY VALVES 87
7.3.1.1 WITHOUT VALVE 88
7.3.1.2 WITH VALVE 88
7.3.2 BY STYLE 88
7.3.2.1 MOLDED CUP 88
7.3.2.2 FLAT FOLD 88
8 MIDDLE EAST & AFRICA N95 MASK MARKET, BY APPLICATION 89
8.1 OVERVIEW 90
8.2 INFECTIOUS DISEASES 93
8.2.1 VIRUSES 94
8.2.2 BACTERIA 94
8.2.3 FUNGI 94
8.2.4 PARASITES 94
8.2.5 OTHERS 94
8.3 RESPIRATORY SAFETY 94
8.3.1 DUSTS 95
8.3.2 FUMES 95
8.3.3 MISTS 96
8.3.4 FOG 96
8.3.5 SPRAYS 96
8.3.6 SMOKES 96
8.3.7 GASES 96
8.3.8 VAPORS 96
8.3.9 OTHERS 96
8.4 ALLERGIES 96
8.4.1 POLLENS 97
8.4.2 DUST MITES 97
8.4.3 PARTICULATES 97
8.4.4 PET ALLERGENS 97
8.4.5 OTHERS 98
8.5 SURGERIES 98
9 MIDDLE EAST & AFRICA N95 MASK MARKET, BY TYPE OF MATERIAL 99
9.1 OVERVIEW 100
9.2 POLYPROPYLENE (PP) 103
9.3 POLYURETHANE 103
9.4 POLYESTER 104
9.5 COTTON 105
10 MIDDLE EAST & AFRICA N95 MASK MARKET, BY USABILITY 106
10.1 OVERVIEW 107
10.2 DISPOSABLE 110
10.3 REUSABLE 111
11 MIDDLE EAST & AFRICA N95 MASK MARKET, BY SIZE 112
11.1 OVERVIEW 113
11.2 STANDARD SIZE 116
11.3 SMALL SIZE 116
11.4 OTHERS 117
12 MIDDLE EAST & AFRICA N95 MASK MARKET, BY END USER 118
12.1 OVERVIEW 119
12.2 HOSPITALS 122
12.2.1 LONG-TERM CARE HOSPITALS 123
12.2.2 ACUTE CARE HOSPITALS 123
12.2.3 NURSING FACILITIES 123
12.2.4 REHABILITATION CENTERS 123
12.3 CLINICS 123
12.4 AMBULATORY SURGICAL CENTERS 124
12.5 DIAGNOSTIC LABORATORIES 124
12.6 PUBLIC SAFETY SERVICE ORGANIZATION 125
12.7 CONSTRUCTION COMPANIES 126
12.8 MANUFACTURING COMPANIES 127
12.9 OIL & GAS COMPANIES 128
12.10 INDIVIDUAL 128
12.11 OTHERS 129
13 MIDDLE EAST & AFRICA N95 MASK MARKET, BY DISTRIBUTION CHANNEL 130
13.1 OVERVIEW 131
13.2 ONLINE SALES 134
13.2.1 ONLINE PHARMACIES 135
13.2.2 OTHERS 135
13.3 OFFLINE SALES 135
13.3.1 HOSPITAL PHARMACIES 136
13.3.2 SUPERMARKET/HYPERMARKET 136
13.3.3 DRUG STORE 136
13.3.4 RETAIL PHARMACIES 136
14 MIDDLE EAST & AFRICA N95 MASK MARKET, BY REGION 137
14.1 MIDDLE EAST AND AFRICA 138
14.1.1 SAUDI ARABIA 148
14.1.2 SOUTH AFRICA 153
14.1.3 U.A.E. 158
14.1.4 ISRAEL 163
14.1.5 EGYPT 168
14.1.6 REST OF MIDDLE EAST AND AFRICA 173
15 MIDDLE EAST & AFRICA N95 MASK MARKET, COMPANY LANDSCAPE 174
15.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA 174
16 SWOT ANALYSIS 175
17 COMPANY PROFILE 176
17.1 3M 176
17.1.1 COMPANY SNAPSHOT 176
17.1.2 REVENUE ANALYSIS 176
17.1.3 COMPANY SHARE ANALYSIS 177
17.1.4 PRODUCT PORTFOLIO 177
17.1.5 RECENT DEVELOPMENT 177
17.2 HONEYWELL INTERNATIONAL INC. 178
17.2.1 COMPANY SNAPSHOT 178
17.2.2 REVENUE ANALYSIS 178
17.2.3 COMPANY SHARE ANALYSIS 179
17.2.4 PRODUCT PORTFOLIO 179
17.2.5 RECENT DEVELOPMENT 179
17.3 KIMBERLY-CLARK 180
17.3.1 COMPANY SNAPSHOT 180
17.3.2 REVENUE ANALYSIS 180
17.3.3 COMPANY SHARE ANALYSIS 181
17.3.4 PRODUCT PORTFOLIO 181
17.3.5 RECENT DEVELOPMENT 181
17.4 CARDINAL HEALTH 182
17.4.1 COMPANY SNAPSHOT 182
17.4.2 REVENUE ANALYSIS 182
17.4.3 COMPANY SHARE ANALYSIS 183
17.4.4 PRODUCT PORTFOLIO 183
17.4.5 RECENT DEVELOPMENT 183
17.5 OWENS & MINOR 184
17.5.1 COMPANY SNAPSHOT 184
17.5.2 REVENUE ANALYSIS 184
17.5.3 COMPANY SHARE ANALYSIS 185
17.5.4 PRODUCT PORTFOLIO 185
17.5.5 RECENT DEVELOPMENT 185
17.6 ALPHAPROTECH 186
17.6.1 COMPANY SNAPSHOT 186
17.6.2 REVENUE ANALYSIS 186
17.6.3 PRODUCT PORTFOLIO 187
17.6.4 RECENT DEVELOPMENT 187
17.7 MAKRITE 188
17.7.1 COMPANY SNAPSHOT 188
17.7.2 PRODUCT PORTFOLIO 188
17.7.3 RECENT DEVELOPMENT 188
17.8 MEDLINE INDUSTRIES, LP 189
17.8.1 COMPANY SNAPSHOT 189
17.8.2 PRODUCT PORTFOLIO 189
17.8.3 RECENT DEVELOPMENT 189
17.9 MOLDEX-METRIC 190
17.9.1 COMPANY SNAPSHOT 190
17.9.2 PRODUCT PORTFOLIO 190
17.9.3 RECENT DEVELOPMENT 191
17.10 PRESTIGE AMRITECH 192
17.10.1 COMPANY SNAPSHOT 192
17.10.2 PRODUCT PORTFOLIO 192
17.10.3 RECENT DEVELOPMENT 192
17.11 THE GERSON COMPANY 193
17.11.1 COMPANY SNAPSHOT 193
17.11.2 PRODUCT PORTFOLIO 193
17.11.3 RECENT DEVELOPMENT 193
18 QUESTIONNAIRE 194
19 RELATED REPORTS 198

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.